Our Science


The activation of myeloid dendritic cells by motolimod leads to an immune cascade that recruits other immune cells to the anti-tumor response. These cells include NK cells and T lymphocytes that enhance tumor cell killing.


VentiRx's Motolimod Ignites an Immune Cascade that Enhances Tumor Cell Killing